Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

被引:76
作者
Singh, Dave [1 ]
Bafadhel, Mona [2 ]
Brightling, Christopher E. [3 ]
Sciurba, Frank C. [4 ]
Curtis, Jeffrey L. [5 ,6 ]
Martinez, Fernando J. [7 ]
Pasquale, Cara B. [8 ]
Merrill, Debora D. [9 ]
Metzdorf, Norbert [10 ]
Petruzzelli, Stefano [11 ]
Tal-Singer, Ruth [9 ]
Compton, Christopher [12 ]
Rennard, Stephen [13 ,14 ]
Martin, Ubaldo J. [15 ]
机构
[1] Univ Manchester, Manchester Univ Natl Hlth Serv Hosp Trust, Div Infect Immun & Resp Med, Southmoor Rd, Manchester M23 9QZ, Lancs, England
[2] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[3] Univ Leicester, Natl Inst Hlth Res Leicester Biomed Res Ctr, Inst Lung Hlth, Dept Resp & Infect Sci, Leicester, Leics, England
[4] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA
[5] VA Ann Arbor Healthcare Syst, Pulm & Crit Care Med, Ann Arbor, MI USA
[6] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[7] Weill Cornell Med Coll, Pulm & Crit Care Med, New York, NY USA
[8] COPD Fdn, COPD Patient Powered Res Network, Washington, DC USA
[9] COPD Fdn, COPD Biomarkers Qualificat Consortium, Miami, FL USA
[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[11] Chiesi Farmaceut, Global Clin Dev, Parma, Italy
[12] GlaxoSmithKline, Global Med Affairs Special & Primary Care, Brentford, Middx, England
[13] AstraZeneca, Biopharmaceut R&D, Cambridge, England
[14] Univ Nebraska Med Ctr, Omaha, NE USA
[15] AstraZeneca, Res & Dev, Gaithersburg, MD USA
关键词
INHALED FLUTICASONE FUROATE; SHORT-TERM RESPONSE; POST-HOC ANALYSIS; SPUTUM-EOSINOPHILIA; EXTRAFINE BECLOMETHASONE/FORMOTEROL; EXACERBATION RISK; CIGARETTE-SMOKING; PARALLEL-GROUP; DOUBLE-BLIND; COPD;
D O I
10.1164/rccm.201912-2384PP
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:660 / 671
页数:12
相关论文
共 80 条
[1]   Treatable traits: toward precision medicine of chronic airway diseases [J].
Agusti, Alvar ;
Bel, Elisabeth ;
Thomas, Mike ;
Vogelmeier, Claus ;
Brusselle, Guy ;
Holgate, Stephen ;
Humbert, Marc ;
Jones, Paul ;
Gibson, Peter G. ;
Vestbo, Jorgen ;
Beasley, Richard ;
Pavord, Ian D. .
EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) :410-419
[2]   Eosinophils and Disease Pathogenesis [J].
Akuthota, Praveen ;
Weller, Peter F. .
SEMINARS IN HEMATOLOGY, 2012, 49 (02) :113-119
[3]   Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability [J].
Alexander, Kristine S. ;
Kazmierczak, Steven C. ;
Snyder, Caryn K. ;
Oberdorf, Jon A. ;
Farrell, David H. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (09) :1875-1882
[4]   Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease A Network Analysis [J].
Angel Martinez-Garcia, Miguel ;
Faner, Rosa ;
Oscullo, Grace ;
de la Rosa, David ;
Soler-Cataluna, Juan-Jose ;
Ballester, Marta ;
Agusti, Alvar .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (09) :1078-1085
[5]  
[Anonymous], 2016, BEST (Biomarkers, EndpointS, and other Tools) Resource
[6]  
Arneth B., 2016, J HEMATOL BROSSARD, V5, P49, DOI DOI 10.14740/JH265W
[7]   Sputum IL-5 Concentration Is Associated with a Sputum Eosinophilia and Attenuated by Corticosteroid Therapy in COPD [J].
Bafadhel, M. ;
Saha, S. ;
Siva, R. ;
McCormick, M. ;
Monteiro, W. ;
Rugman, P. ;
Dodson, P. ;
Pavord, I. D. ;
Newbold, P. ;
Brightling, C. E. .
RESPIRATION, 2009, 78 (03) :256-262
[8]  
Bafadhel M, 2019, EUR RESPIR J, V52
[9]  
BAFADHEL M, 2009, AM J RESP CRIT CARE, V179
[10]   Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials [J].
Bafadhel, Mona ;
Peterson, Stefan ;
De Blas, Miguel A. ;
Calverley, Peter M. ;
Rennard, Stephen I. ;
Richter, Kai ;
Fageras, Malin .
LANCET RESPIRATORY MEDICINE, 2018, 6 (02) :117-126